Research and Development
AbbVie expands oncology portfolio with $5.8 billion Stemcentrx acquisition
April 29, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, acquisition, rova-t, stremcentrx, takeover
Abbott to purchase St Jude Medical in $25 billion deal
April 28, 2016 Manufacturing and Production, Research and Development, Sales and Marketing $25, 25 billion, Abbott, Medical device, acquisition, purchase, st jude medical
Valeant’s outgoing boss tells Senate committee he “regrets” drug price rises
April 28, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Senate, Valeant, admits, aggressive, committee, drug price, pearson, rises
PTC Therapeutics appoints Tuyen Ong as chief medical officer
April 28, 2016 Business Services, Research and Development
Sanofi makes unsolicited $9.8 billion bid for Medivation
April 28, 2016 Research and Development, Sales and Marketing M&A, MA, Medivation, Sanofi, deal, unsolicited offer
GlaxoSmithKline Q1 earnings up 14% on new product sales
April 27, 2016 Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Q1, earnings, results, revenue, sales
New head of R&D at Biogen
April 27, 2016 Research and Development Biogen, Pfizer, R&D, erhlers, michael, michael erhlers, research and development
NICE backs BMS’ paclitaxel in ovarian cancer; drops Eli Lilly’s Gemzar, J&J’s Yondelis
April 27, 2016 Research and Development, Sales and Marketing BMS, Eli Lilly, J&J, JJ, NICE, ovarian cancer, regulation
NICE gives green light to Novartis’s heart drug Entresto
April 27, 2016 Research and Development, Sales and Marketing Entresto, NHS, NICE, Novartis, benefit, heart failure, patients
Remaining in the EU is vital for UK’s cancer research strength, say leading oncologists
April 27, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, EU, Europe, UK, brexit, britain, cancer research, cede, exit, implications, negative, oncology, pharma
Baxter hikes 2016 earnings view driven by strong Q1 results
April 27, 2016 Research and Development, Sales and Marketing Baxalta, FY, Q1, baxter, earnings, outlook, results, revenue
Eli Lilly Q1 earnings miss estimates, ups FY view; shares drop 2%
April 27, 2016 Research and Development, Sales and Marketing Eli Lilly, FY, Q1, earnings, revenue, sales
ABPI welcomes recommendations from NHS specialised services report
April 27, 2016 Research and Development, Sales and Marketing ABPI, NHS, NHS England, NICE, National Audit Office, report, specialised services
Shire to close Hampshire base and relocate jobs, say reports
April 27, 2016 Manufacturing and Production, Research and Development Jobs, Shire, close, factory, hampshire, loss, relocate
AstraZeneca sells US rights for gout treatment to Ironwood Pharmaceuticals
April 27, 2016 Research and Development, Sales and Marketing AstraZeneca, Ironwood, Licencing, Zurampic, agreement, exclusive, gout, lesinurad, sales
